ArticleJournal of immunotherapy (Hagerstown, Md. : 1997)2011

A phase 1 study of a vaccine targeting preferentially expressed antigen in melanoma and prostate-specific membrane antigen in patients with advanced solid tumors.

Jeffrey S Weber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.